These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 38415587)
1. Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1 Koehn LM; Steele JR; Schittenhelm RB; Turner BJ; Nicolazzo JA Mol Pharm; 2024 Apr; 21(4):1756-1767. PubMed ID: 38415587 [TBL] [Abstract][Full Text] [Related]
2. Plasma, brain and spinal cord concentrations of caffeine are reduced in the SOD1 Koehn LM; Jalaldeen R; Pelle J; Nicolazzo JA Eur J Pharm Biopharm; 2024 Oct; 203():114434. PubMed ID: 39098618 [TBL] [Abstract][Full Text] [Related]
3. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1 Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164 [TBL] [Abstract][Full Text] [Related]
4. Exercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1 Hazell G; McCallion E; Ahlskog N; Sutton ER; Okoh M; Shaqoura EIH; Hoolachan JM; Scaife T; Iqbal S; Bhomra A; Kordala AJ; Scamps F; Raoul C; Wood MJA; Bowerman M Skelet Muscle; 2024 Oct; 14(1):23. PubMed ID: 39396990 [TBL] [Abstract][Full Text] [Related]
5. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1) Silverman JM; Christy D; Shyu CC; Moon KM; Fernando S; Gidden Z; Cowan CM; Ban Y; Stacey RG; Grad LI; McAlary L; Mackenzie IR; Foster LJ; Cashman NR J Biol Chem; 2019 Mar; 294(10):3744-3759. PubMed ID: 30635404 [TBL] [Abstract][Full Text] [Related]
6. Early deficits in GABA inhibition parallels an increase in L-type Ca Venugopal S; Ghulam-Jhelani Z; Ahn IS; Yang X; Wiedau M; Simmons D; Chandler SH Neurobiol Dis; 2023 Feb; 177():105992. PubMed ID: 36623607 [TBL] [Abstract][Full Text] [Related]
7. Proteomics analysis indicates the involvement of immunity and inflammation in the onset stage of SOD1-G93A mouse model of ALS. Chen L; Wang N; Zhang Y; Li D; He C; Li Z; Zhang J; Guo Y J Proteomics; 2023 Feb; 272():104776. PubMed ID: 36423857 [TBL] [Abstract][Full Text] [Related]
8. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1 Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622 [TBL] [Abstract][Full Text] [Related]
9. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase. Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927 [TBL] [Abstract][Full Text] [Related]
10. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1 MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712 [TBL] [Abstract][Full Text] [Related]
11. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis. Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation. Liu X; Zhang J; Li J; Song C; Shi Y Mol Metab; 2022 Sep; 63():101536. PubMed ID: 35772643 [TBL] [Abstract][Full Text] [Related]
14. ALS-associated mutation SOD1 Wang H; Yi J; Li X; Xiao Y; Dhakal K; Zhou J Bone; 2018 Jan; 106():126-138. PubMed ID: 29030231 [TBL] [Abstract][Full Text] [Related]
15. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis. Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725 [TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1 Xu X; Yang Q; Liu Z; Zhang R; Yu H; Wang M; Chen S; Xu G; Shao Y; Le W Neurobiol Dis; 2023 Jun; 181():106110. PubMed ID: 37001614 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model. Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394 [TBL] [Abstract][Full Text] [Related]
18. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
19. Characterizing the multiple roles of FGF-2 in SOD1 Kefalakes E; Böselt S; Sarikidi A; Ettcheto M; Bursch F; Naujock M; Stanslowsky N; Schmuck M; Barenys M; Wegner F; Grothe C; Petri S J Cell Physiol; 2019 May; 234(5):7395-7410. PubMed ID: 30370540 [TBL] [Abstract][Full Text] [Related]
20. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis. Chang Q; Martin LJ J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]